Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$593M |
| 2 |
Abbott
ABT
|
+$259M |
| 3 |
AutoZone
AZO
|
+$204M |
| 4 |
AABA
Altaba Inc
AABA
|
+$186M |
| 5 |
D.R. Horton
DHI
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$215M |
| 2 |
Public Service Enterprise Group
PEG
|
+$211M |
| 3 |
Applied Materials
AMAT
|
+$203M |
| 4 |
Intuitive Surgical
ISRG
|
+$194M |
| 5 |
ConocoPhillips
COP
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.87% |
| 2 | Technology | 11.53% |
| 3 | Consumer Discretionary | 11.36% |
| 4 | Healthcare | 11.05% |
| 5 | Industrials | 10.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
CALL
Edwards Lifesciences
EW
$47.8B
| $1.13M | ﹤0.01% |
30,000
-120,000
| -80% | -$4.4M |
|
2627
iShares Biotechnology ETF
IBB
$9.44B
| $1.13M | ﹤0.01% |
+10,559
| New | +$1.13M |
|
|
AKTX
2628
Akari Therapeutics
AKTX
$14.8M
| $1.13M | ﹤0.01% |
325
+181
| +126% | +$698K |
|
2629
Calix
CALX
$2.32B
| $1.12M | ﹤0.01% |
188,987
+168,917
| +842% | +$1.02M |
|
|
GES
2630
DELISTED
Guess Inc
GES
| $1.12M | ﹤0.01% |
+66,567
| New | +$1.1M |
|
|
CBM
2631
DELISTED
Cambrex Corporation
CBM
| $1.12M | ﹤0.01% |
23,407
-493,900
| -95% | -$24.5M |
|
2632
Children's Place
PLCE
$52.8M
| $1.12M | ﹤0.01% |
7,728
-36,966
| -83% | -$4.5M |
|
2633
PUT
iRhythm Holdings
IRTC
$3.69B
| $1.12M | ﹤0.01% |
20,000
+10,000
| +100% | +$523K |
|
2634
Strategic Education
STRA
$1.78B
| $1.12M | ﹤0.01% |
12,489
+9,191
| +279% | +$849K |
|
2635
BCB Bancorp
BCBP
$179M
| $1.11M | ﹤0.01% |
76,882
+50,889
| +196% | +$731K |
|
|
EGRX
2636
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.11M | ﹤0.01% |
+20,841
| New | +$1.16M |
|
2637
PUT
Align Technology
ALGN
$12B
| $1.11M | ﹤0.01% |
5,000
-40,000
| -89% | -$9.09M |
|
2638
Summit Therapeutics
SMMT
$10.5B
| $1.11M | ﹤0.01% |
99,873
+22,759
| +30% | +$254K |
|
|
AVXS
2639
PUT
DELISTED
AveXis, Inc. Common Stock
AVXS
| $1.11M | ﹤0.01% |
+10,000
| New | +$1M |
|
|
CWBC
2640
Community West Bancshares
CWBC
$686M
| $1.1M | ﹤0.01% |
54,495
+14,484
| +36% | +$296K |
|
2641
Verastem
VSTM
$534M
| $1.1M | ﹤0.01% |
29,801
+14,347
| +93% | +$648K |
|
|
AKRX
2642
DELISTED
Akorn Inc
AKRX
| $1.1M | ﹤0.01% |
+34,080
| New | +$1.12M |
|
|
CO
2643
DELISTED
Global Cord Blood Corporation
CO
| $1.1M | ﹤0.01% |
110,375
-14,156
| -11% | -$155K |
|
2644
BioLife Solutions
BLFS
$1.46B
| $1.09M | ﹤0.01% |
182,550
+164,324
| +902% | +$947K |
|
2645
PUT
Illumina
ILMN
$28.7B
| $1.09M | ﹤0.01% |
5,140
| – | – |
|
2646
Ooma
OOMA
$571M
| $1.09M | ﹤0.01% |
91,193
+54,019
| +145% | +$575K |
|
2647
Westwood Holdings Group
WHG
$186M
| $1.09M | ﹤0.01% |
16,426
+8,626
| +111% | +$573K |
|
2648
Vitamin Cottage Natural Grocers
NGVC
$729M
| $1.09M | ﹤0.01% |
+121,713
| New | +$801K |
|
2649
Zumiez
ZUMZ
$328M
| $1.08M | ﹤0.01% |
52,040
-4,365
| -8% | -$83.5K |
|
2650
Invesco Senior Loan ETF
BKLN
$6.97B
| $1.08M | ﹤0.01% |
46,929
-275,481
| -85% | -$6.36M |
|
Similar funds
Millennium Management's Q4 2017 Portfolio in Review
As of Q4 2017, Millennium Management held 4,357 positions worth $72.5B, up 10% from $65.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Millennium Management deployed $3.05B of net new capital in Q4 2017, opening 897 new positions and adding to 1,473 existing holdings. Its largest new stake was Viatris: 2,905,317 shares worth $123M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $215M trimmed.
- Millennium Management's largest Q4 2017 buy was Viatris: 2,905,317 shares worth $123M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $593M increase.
- Millennium Management's biggest Q4 2017 reduction was Honeywell, cutting an estimated $215M.
- Millennium Management fully exited Paychex in Q4 2017, selling an estimated $66.4M.
- Millennium Management's ten largest holdings make up 6.7% of its $72.5B portfolio in Q4 2017.
- Millennium Management opened 897 new positions and closed 601 in Q4 2017.
- Millennium Management's portfolio value rose 10% quarter-over-quarter to $72.5B.
Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.